✦ LIBER ✦

The futility index. An approach to the cost-effective termination of randomized clinical trials

✍ Scribed by James H. Ware; James E. Muller; Eugene Braunwald

Book ID: 115680628
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 922 KB
Volume: 78
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(85)90407-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toward Less Futile Surgery in Non-Small

Toward Less Futile Surgery in Non-Small Cell Lung Cancer? A Randomized Clinical Trial to Evaluate the Cost-Effectiveness of Positron Emission Tomography

✍ Harm van Tinteren; Otto S. Hoekstra; Egbert F. Smit; Paul Verboom; Maarten Boers 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

96 Childhood ALL: from the randomized cl

96 Childhood ALL: from the randomized clinical trials to an evidence-based approach

✍ G. Masera 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 79 KB

On the probability of cost-effectiveness

On the probability of cost-effectiveness using data from randomized clinical trials

✍ Andrew R Willan 📂 Article 📅 2001 🏛 BioMed Central 🌐 English ⚖ 327 KB

The cost effectiveness of a run-in strat

The cost effectiveness of a run-in strategy in a randomized clinical trial

✍ Kenneth B. Schechtman; Mae E. Gordon 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Summary of the dietary approaches to sto

Summary of the dietary approaches to stop hypertension (dash) randomized clinical trial

✍ William S. Getchell; Laura P. Svetkey; Lawrence J. Appel; Thomas J. Moore; Georg 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 135 KB

Estimating the cost-effectiveness of an

Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach

✍ Paul C. Lambert; Lucinda J. Billingham; Nicola J. Cooper; Alex J. Sutton; Keith 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

## Abstract There is an increasing need to establish whether health‐care interventions are cost effective as well as clinically effective. It is becoming increasingly common for cost studies to be incorporated into clinical trials, either on all patients or more usually on a subset of patients. Est